Study on eye changes in people with PXE
Part of Blood & lymphatic, Eyes & vision, Genetic & congenital, Heart & circulation, Skin clinical trials.
This study uses special eye imaging to track changes caused by PXE, a rare genetic condition. It may help researchers understand how PXE affects the eyes over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with PXE (pseudoxanthoma elasticum), a condition that affects elastic tissue in the body.
- Your eyes are clear enough for imaging (no major clouding or cataracts).
- You can keep your head still during the eye scans.
- You do not have any other serious eye disease that is not caused by PXE.
- You do not have a medical condition that would make it hard to complete the study exams.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests a medicine to help prevent abnormal calcium (called ectopic mineralization) from building up in people with pseudoxanthoma elasticum (PXE). It aims to slow or reduce new damage over time.
This study looks at blood flow in a layer of the eye called the choriocapillaris in people with pseudoxanthoma elasticum (PXE). It compares these findings with healthy volunteers to understand eye changes before they become severe.
This study looks at whether a new way of organizing care helps patients with pseudoxanthoma elasticum (PXE). It also asks some patients about their experience with the new care setup.
This trial tests a compound that affects certain chemicals in your body (purines) to see if it helps people with pseudoxanthoma elasticum (PXE), a rare genetic condition affecting skin, eyes, and blood vessels.
This trial studies whether taking PPI-type supplements can slow or reduce unwanted calcification in people with PXE. It’s meant to help manage disease changes caused by abnormal calcium deposits, based on your medical testing.
This study looks at blood or DNA-related factors that may explain why certain glaucoma and related eye conditions happen. It may help researchers understand risk and causes across different glaucoma types.
Hear when a new Pseudoxanthoma Elasticum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.